How many institutions held ABUS - Arbutus Biopharma Corp - Common Shares, without par value in Q4 2023?

110 institutional investors reported ABUS - Arbutus Biopharma Corp - Common Shares, without par value for Q4 2023. Use the holders table for investor-level position and value details.

Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

Q: What does CUSIP 03879J100 represent in this 13F holders report?

CUSIP 03879J100 is the security identifier for ABUS - Arbutus Biopharma Corp - Common Shares, without par value used to aggregate holder disclosures.

CUSIP: 03879J100

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / Common Shares, without par value
Total 13F shares: 78,913,089
Total 13F value: $197,297,266
Share change: +4,244,560
Put/Call ratio: 92%
SEC-reported price per share: $2.50
Number of holders: 110
Value change: +$10,900,831
Number of buys: 45
Number of sells: 36
Shares outstanding: 197,420,670

Security key

03879J100

Report period

Q4 2023

Institutions

110

Top holders

ABUS full security history Ownership snapshot Full 13F holder table Arbutus Biopharma Corp SEC filings Arbutus Biopharma Corp company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Whitefort Capital Managem...

Disclosed value leader

Whitefort Capital Managem...

Comparable rows

15/15

Latest evidence

30 Sep 2023

13F Lead comparable stake: 6% Showing 1-6 of 15 holder rows.

Quick read

Whitefort Capital Management, LP leads the comparable SEC ownership view at 6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Whitefort Capital Management, LP's linked filing trail.

Comparable ownership Top 5

Whitefort Capital Management, LP 6%

BlackRock Finance, Inc. 5.2%

Two Seas Capital LP 4.2%

VANGUARD GROUP INC 3%

MORGAN STANLEY 2.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Whitefort Capital Management, LP	13F Company 13F	6%	$24,147,818 11,895,477 shares	—	30 Sep 2023
BlackRock Finance, Inc.	13F Company 13F	5.2%	$20,856,506 10,274,141 shares	—	30 Sep 2023
Two Seas Capital LP	13F Company 13F	4.2%	$16,810,061 8,280,818 shares	—	30 Sep 2023
VANGUARD GROUP INC	13F Company 13F	3%	$12,074,485 5,948,022 shares	—	30 Sep 2023
MORGAN STANLEY	13F Company 13F	2.7%	$10,680,093 5,261,130 shares	—	30 Sep 2023
Woodline Partners LP	13F Company 13F	2.4%	$9,581,403 4,719,903 shares	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

110

78,913,089

Rows available

110

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

110

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 value	Q4 2023 value	Value change	Value Chg %